2,5-Dihydro-1H-Pyrrole Hydrochloride

In the commercial production of 3-aminopyrrolidine—the key side-chain precursor for the fluoroquinolone antibiotic tosufloxacin tosilate—2,5-dihydro-1H-pyrrole hydrochloride is subjected to direct, uncatalyzed ammonolysis under rigorously anhydrous conditions to suppress pyrrolidine ring-opening and dimerization. The feeding protocol stipulates a molar ratio of anhydrous ammonia (99.99% purity) to pyrroline salt of 4.2:1 to 4.8:1, with the ammonia charged into a pre-cooled (−10 °C) suspension of the salt in tetrahydrofuran (3.0 L per kg of substrate). Moisture levels in the solvent must be verified by Karl Fischer titration to remain below 150 ppm, and the reactor headspace is purged with dry nitrogen for at least three cycles before sealing. Manufacturing is conducted in a 500-L Hastelloy C-276 high-pressure autoclave (design pressure 200 bar at 300 °C) equipped with a gas-entrainment impeller and external half-pipe jacket for heat transfer. The reaction mass is heated to 85–95 °C, generating an autogenous pressure of 120–145 bar, and held for 14–18 h. A critical operational boundary is the onset of a secondary exotherm above 105 °C, where cyclodimerization accelerates, dropping yield below 60%. Crude 3-aminopyrrolidine is isolated by flashing off ammonia, filtering inorganic salts, and vacuum distillation (bp 67–70 °C at 50 mbar) to obtain a colorless oil with GC purity >98.5%. The site must adhere to ICH Q7 Good Manufacturing Practice for active pharmaceutical ingredient starting materials, with specific controls on genotoxic impurities per ICH M7(R2); the final intermediate is routinely tested against the European Pharmacopoeia monograph 01/2023:2704 for 3-aminopyrrolidine. The downstream coupling to the quinolone core is performed via aromatic nucleophilic substitution at C-7, ultimately yielding tosufloxacin tosilate monohydrate, a broad-spectrum gram-positive antibacterial listed in the Japanese Pharmacopoeia 18th edition.

Can Boc Protection of 3-Pyrroline Be Scaled Beyond 500-L Reactors?

Boc anhydride-mediated N-protection of 2,5-dihydro-1H-pyrrole is a foundational step in medicinal chemistry, yet transferring the classical biphasic procedure to multi-purpose 2,000-L glass-lined vessels introduces hydrolysis sensitivity and thermal runaway risks that demand engineered controls. The free base is liberated from the hydrochloride salt by dropwise addition of 30% w/w sodium hydroxide to a stirred aqueous slurry (pH adjusted to 9.5–10.0 at 0–5 °C), after which di-tert-butyl dicarbonate is metered at a molar ratio of 1.12–1.20 mol/mol relative to the theoretical free amine, maintaining an internal temperature below 8 °C. Minimum stir rates of 150 rpm for a retreat-curve impeller are required to sustain the liquid-liquid interface area; production logs document that excursions in pH above 10.5 promote rapid decomposition of Boc₂O and evolution of carbon dioxide, causing foam-over in inadequately headspaced reactors. The downstream process consists of phase separation, heptane extraction (3 × 200 L), combined organic washes with 2% w/v citric acid and brine, atmospheric concentration, and fractional distillation under reduced pressure (72–74 °C at 30 mbar). Full-scale production requires respiratory protection against tert-butyl alcohol vapor and continuous monitoring of extracted aqueous phase COD to meet local discharge limits. The resulting N-Boc-3-pyrroline is released as a colorless to pale yellow liquid with assay ≥98.5% by GC, moisture ≤0.20%, and single largest impurity ≤0.15%, conforming to the supplier’s specification registered under REACH (EC No. 700-234-7). Residual 1,4-dioxane (if used as cosolvent) is controlled below 380 ppm according to ICH Q3C Option 2 limits. This protected synthon is subsequently employed in Suzuki-Miyaura cross-couplings to generate biaryl pyrroline libraries for kinase inhibitor programs, and the bulk intermediate is a common catalog item for preclinical synthesis.

Azabicyclo[2.2.1]heptane Dienophile Scope at Ambient Pressure

Maleimides, 1,2,3-triazinediones, and certain acrylate esters engage 2,5-dihydro-1H-pyrrole hydrochloride in a thermal [4+2] cycloaddition through its transient enamine tautomer, requiring a stoichiometric excess of the pyrroline component to counter retro-Diels-Alder cleavage at elevated temperature. In a standard preparation of N-substituted 7-azabicyclo[2.2.1]hept-2-ene exo-adducts, the hydrochloride is neutralized in situ with 1.05 equivalents of triethylamine in dry dichloromethane, and the dienophile (e.g., N-phenylmaleimide) is introduced at a mole ratio of 1.0:1.20 (dienophile:pyrroline), followed by reflux (39–41 °C) for 6–8 hours. Because the cycloadduct precipitates or crystallizes upon cooling, gravimetric monitoring determines the endpoint; typical isolated yields range between 72% and 85% depending on headspace nitrogen integrity—oxygen ingress leads to N-oxide formation detectable by LC-MS at m/z +16. The crude product is recrystallized from ethyl acetate/hexane (1:3 v/v) to afford a white crystalline solid with melting point 152–154 °C and HPLC purity >99.0%. For commercial supply of these tropane-related building blocks, the process is operated under ISO 9001:2015 quality management, with specific GLP batch records when destined for CNS receptor radioligand competitions (evaluated according to OECD 409 guidelines). The final end-products are orthosteric ligands of neuronal nicotinic acetylcholine receptors (α4β2 subtype), progressing through phase I clinical imaging studies as positron emission tomography tracers. Residual solvent specifications comply with USP <467> Method IV; palladium content (if hydrogenation catalysts are later used) is monitored by ICP-MS to <10 µg/g.

Direct asymmetric hydrogenation of N-acyl-2,5-dihydro-1H-pyrrole generates 3-substituted pyrrolidines that function as privileged cores for chiral phosphine ligands, exemplified by the (S)-proline-derived P-chiral auxiliary families. A factory-scale process involves charging N-benzoyl-3-pyrroline (prepared in one pot from the hydrochloride and benzoyl chloride at 1.02 mol equiv. in aqueous sodium carbonate/dichloromethane at 0–5 °C) into a 50-L stainless steel hydrogenation autoclave together with [Rh(COD)((S)-Segphos)]BF₄ at a substrate-to-catalyst ratio of 2,000:1. The sealed vessel is pressurized with hydrogen to 60 bar and held at 45 °C for 22–26 h, with continuous uptake monitoring; a deficiency in hydrogen purity (≥99.999%) results in catalyst ligand degradation and enantiomeric excess (e.e.) erosion below 94%. Upon depressurization and removal of dichloromethane solvent, the chiral amide is crystallized from toluene/n-heptane, filtered, and dried under vacuum (40 °C, 10 mbar) to a melting range of 88–91 °C and optical rotation [α]²⁰D = −32.5° (c=1.0, CHCl₃). The intermediate is then transformed through a phosphine oxide displacement sequence into a bidentate ligand that meets the specifications for electronic-grade fine chemicals: Pd residue below 5 ppm, iron below 15 ppm, and total chlorides below 50 ppm, as per an internal standard aligned with ASTM E1019-18 for metals determination. The terminal products are homogeneous catalysts sold to pharmaceutical companies for scale-up of key chiral hydrogenation steps in Type II diabetes medications, where each batch certificate references compliance with 21 CFR 210/211 if used in registered manufacturing. Catalyst selectivity data (turnover number >50,000, e.e. 98.2%) are generated per each lot and reported alongside the certificate of analysis.

When [18F]Fluorination Demands Pre-Activated Pyrroline Synthons

The 2,5-dihydro-1H-pyrrole framework serves as a versatile precursor for ¹⁸F-fluoroalkylated pyrrolidine positron emission tomography (PET) imaging agents, where the hydrochloride salt is converted to a toluenesulfonate leaving-group derivative with pinpoint stoichiometry to maximize radiochemical yield in automated synthesis modules (e.g., GE TRACERlab FX_FN or Synthra RNplus). A representative preparation starts with N-alkylation using 1.1 eq. of 1-bromo-2-fluoroethane in acetonitrile under reflux (82 °C, 16 h) following free-basing with potassium carbonate, giving the N-(2-fluoroethyl)pyrroline intermediate. This intermediate is then dihydroxylated with a catalytic amount of osmium tetroxide (0.5 mol%) and N-methylmorpholine N-oxide (1.3 eq.) in acetone-water, leading to a diol that is converted to a bis-tosylate using tosyl chloride (2.5 eq.) in pyridine at −10 °C. The critical addition ratio is the molar amount of Kryptofix 2.2.2/K₂CO₃ used during the final [¹⁸F]fluorination step, where the precursor (bis-tosylate) is loaded at 10–15 mg per synthesis run (0.016–0.024 mmol) and reacted with cyclotron-produced [¹⁸F]fluoride in a 0.7 mL reactor at 100 °C for 15 min. The crude ¹⁸F-labeled product is purified via semi-preparative HPLC (column: Phenomenex Gemini C18, 250 × 10 mm, mobile phase: 40% EtOH/60% 0.02 M NaH₂PO₄) and formulated in <10% ethanol in saline. Facilities performing this cGMP radiolabeling comply with 21 CFR Part 212 (PET drug current good manufacturing practice) and USP <823> for radiopharmaceuticals, with final sterile filtration and apyrogenicity testing per USP <71> and <85>. The terminal product types are ¹⁸F-pyrrolidine-based tracers used in oncology neurology studies, such as imaging agents for metabotropic glutamate receptor subtype 5 (mGluR5).

Pyrrolinium Ionic Liquids as Reactive Extraction Solvents

Quaternization of 2,5-dihydro-1H-pyrrole hydrochloride with dimethyl sulfate or diethyl sulfate after amine liberation yields N,N-dialkyl-3-pyrrolinium salts, a class of low-viscosity ionic liquids that function as phase-transfer catalysts and extractants for heavy metals from acidic aqueous streams. The synthesis sequence implemented in pilot-scale campaigns begins with dissolving the hydrochloride in water, adjusting to pH 10 with 50% NaOH, and extracting the free base into dichloromethane; the organic layer is dried over molecular sieves 3Å and then combined with diethyl sulfate at a molar ratio of 1:1.05 under a nitrogen blanket at −5 °C to control the quaternization exotherm. The reaction temperature is maintained below 15 °C by a jacket-controlled 100-L glass-lined reactor with an anchor agitator (80 rpm) to prevent localized hotspot formation that degrades the product to tarry byproducts. After 8 hours, the crude ionic liquid is washed with ethyl acetate (3 × 10 L) and dried under high vacuum (0.1 mbar, 60 °C) to a water content of <0.1% w/w (Karl Fischer). The N,N-diethyl-3-pyrrolinium ethyl sulfate obtained meets a specification of >97.0% purity by ion chromatography, with sulfate content within ±2% of theoretical. For deployment in metal recovery from spent lithium-ion battery leachates, the liquid-liquid extraction efficiency for cobalt(II) at pH 2.5 reaches 87.3% in a single stage, evaluated according to ASTM D3866-18 for extraction systems. End-product compositions are registered under EU REACH as non-harmonised intermediates, and workplace exposure limits are benchmarked against the permitted daily exposure of 0.5 mg/m³ for the corresponding sulfate aerosol (MAK value). The terminal function is as a task-specific ionic liquid formulated for hydrometallurgical loops in urban mining operations.